Bruker:AWArdour/sandkasse

{{under utvikling}}

Lifecare AS
Org.form		LLC
Bransje		Medical technology, Health care, Manufacturing
Hovedkontor		Bergen, Norway
Produkt(er)		Continuos glucose monitors (CGM)
Nøkkelpersoner		Joacim Holter (CEO), Prof. Dr. med. Dr. rer. nat. Andreas Pfützner (CSO)

Lifecare AS

Lifecare AS is a medical technology firm based in Norway, with subsidiary offices in Germany and the UK, that specializes in creating small-scale continuous glucose monitors (CGMs). The company was founded in 2006 and became operational soon after. Lifecare AS is publicly listed on Euronext Growth Oslo with ticker "LIFE".

Technology

Technology-wise, Lifecare's CGMs are implantable subcutaneously using a needle, typically in the wrist. The CGMs, which are about the size of a grain of rice, use osmotic pressure systems to determine glucose levels in the blood. The monitor, in its most basic form, is a thin, rectangular ceramic tile with two windows etched into it. The device includes a nanoporous, semipermeable membrane that forms two chambers containing concanavalin A-dextran complex and a reference liquid. Glucose concentrations in the blood can be determined by measuring the deformation of the membrane resulting from osmotic pressure changes caused by glucose's presence.

History

2000s

• A double membrane patent was warranted. [1]

2010s

• An augmented osmotic pressure patent was warranted.

• A dual sensor patent was warranted.

2018

• Listed on Euronext Growth Oslo [9]

2020s

• The company had its pilot clinical study finished in 2022, confirming functionality observed in animal trials. [1]

• Preperations for a second and third clinical study were started. [1]

Structure

Lifecare's headquarters is situated in Bergen, Norway, while the research and development activities are conducted in Mainz, Germany. The company collaborates with partners across Europe on various development projects. Lifecare is structured with a management team, a board of directors, and a scientific board.

Management

• Joacim Holter, CEO [2]

• Prof. Dr. med. Dr. rer. nat. Andreas Pfützner, CSO [2]

Board of directors

The Board of Directors is composed of induviduals working within diabetes technology and legal matters, who actively participate in technical development and other operations of the company.

• Morten Foros Krohnstad, Chairman

• Trine Teigland, board member

• Prof. Dr. Lutz Heinemann, board member

• Bo Petersson, board member

• Hans Johan Hekland, board member

Scientific Advisory Board

The Scientific Advisory Board of Lifecare is made up of experts (various individuals working within the field of) in diabetes technology, clinical medicine, endocrinology, physics and nanotechnology.

• Prof. David C. Klonoff, Chairman

• Prof. Dr. Lutz Heinemann, member

• Prof. Kåre Birkeland, member

• Prof. Dr. Michael Huth, member

Consultants

• Prof. Tony James, Scientific Consultant

Subsidiary

• Lifecare Laboratory - Mainz, Germany [5]

• Lifecare NanoBioSensors – Reutlingen, Germany

Corporation

• University of Bath[4]

Sources

[1] “Investor presentation October 2022”, Lifecare.no. Retrieved 09.02.23

[2] “About”, Lifecare.no. Retrieved 09.02.23

Notability

[3] “Lifecare AS”, norwayhealthtech.com. Retrieved 02.02.23

[4] “University [of Bath] partnering with Norwegian health tech company to advance world’s smallest glucose sensor”, bath.ac.uk. Retrieved 09.02.23

[5] “Lifecare har inngått samarbeid med tysk universitet”, medwatch.no. Retrieved 09.02.23

[6] “Lifecare fikk godkjennelse som varslet – aksjen gikk opp 51 prosent”, bt.no. Retrieved 09.02.23

[7] “Lifecare – et Norsk eventyr innen farmasi”, finansavisen.no. Retrieved 09.02.23

[8] “Den er på størrelse med et riskorn. Målet er at den skal gjøre diabetesbehandlingen mye billigere og bedre.”, aftenposten.no. Retrieved 09.02.23

[9] “Kunngjøringer”, brønnøysundsregisteret.no. Retrieved 09.02.23